Friesen lecture with Dr. Lorne Tyrrell

Contributions to Viral Hepatitis: Vaccine Task Force and COVID-19

Thursday, November 17

11 a.m. to 12 p.m.

Needles Hall 3318/3308 or virtually (please register below)

FCIHR logo

Dr. Lorne Tyrrell

Waterloo faculty, staff and students are invited to attend the Friesen lecture featuring Dr. David Lorne J. Tyrrell, recipient of the 2021 Henry G. Friesen International Prize in Health Research, awarded by Friends of CIHR.

Dr. Tyrrell is a Distinguished Professor at the University of Alberta with major interests in the prevention and treatment of viral diseases.

His multi-faceted career in academic medicine, virology, pharmaceutical enterprise, and dedicated advocacy for health research in Canada are being honoured with the 2021 Henry G. Friesen International Prize in Health Research. Dr. Lorne Tyrrell is a gold medalist at the University of Alberta, where he obtained an MD in 1968 and a PhD at Queen’s University in 1972. He completed Internal Medicine and sub-specialty training in Infectious Diseases and post-doctoral training in Virology at the Karolinska Institute.

Dr. Tyrrell’s most celebrated life saving accomplishment in collaboration with Morris Robbins was the licensing of the first oral anti-viral drug for chronic HBV (Lamivudine) in 200 countries. This led to the establishment of the Li Ka Shing Institute of Virology in 2010 at the University of Alberta, where Dr. Tyrrell is its Founder and Director.

Read his full biography.

Please register below as seating is limited.